These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 37690425)
1. Importance of screening severe COVID-19 patients for IFN-λ1, IL-6 and anti-S1 IgG levels. Kenanoğlu OB; Gül A; Can H; Karakavuk M; Erkunt Alak S; Korukluoğlu G; Altaş AB; Pullukçu H; Değirmenci Döşkaya A; Karakavuk T; Gül C; Çiçek C; Taşbakan MS; Çinkooğlu A; Ün C; Gürüz AY; Avcı M; Karasulu E; Tekin Ş; Döşkaya M; Işıkgöz Taşbakan M Cytokine; 2023 Nov; 171():156357. PubMed ID: 37690425 [TBL] [Abstract][Full Text] [Related]
2. Impact of IL-34, IFN-α and IFN-λ1 on activity of systemic lupus erythematosus in Egyptian patients. Adel Y; Sadeq Y Reumatologia; 2020; 58(4):221-230. PubMed ID: 32921829 [TBL] [Abstract][Full Text] [Related]
3. IFN-λ1 with Th17 axis cytokines and IFN-α define different subsets in systemic lupus erythematosus (SLE). Oke V; Brauner S; Larsson A; Gustafsson J; Zickert A; Gunnarsson I; Svenungsson E Arthritis Res Ther; 2017 Jun; 19(1):139. PubMed ID: 28619037 [TBL] [Abstract][Full Text] [Related]
4. Different Profiles of Antibodies and Cytokines Were Found Between Severe and Moderate COVID-19 Patients. Guo Y; Li T; Xia X; Su B; Li H; Feng Y; Han J; Wang X; Jia L; Bao Z; Li J; Liu Y; Li L Front Immunol; 2021; 12():723585. PubMed ID: 34489974 [TBL] [Abstract][Full Text] [Related]
5. Interferons and systemic sclerosis: correlation between interferon gamma and interferon-lambda 1 (IL-29). Dantas AT; Gonçalves SM; Pereira MC; de Almeida AR; Marques CD; Rego MJ; Pitta Ida R; Duarte AL; Pitta MG Autoimmunity; 2015; 48(7):429-33. PubMed ID: 26057401 [TBL] [Abstract][Full Text] [Related]
6. Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity. Wu Q; Yang Q; Lourenco E; Sun H; Zhang Y Arthritis Res Ther; 2011 Jun; 13(3):R88. PubMed ID: 21679442 [TBL] [Abstract][Full Text] [Related]
7. Entecavir-induced interferon-λ1 suppresses type 2 innate lymphoid cells in patients with hepatitis B virus-related liver cirrhosis. Wang SQ; Shen Y; Li J; Liu Y; Cheng LS; Wu SD; She WM; Jiang W J Viral Hepat; 2021 May; 28(5):795-808. PubMed ID: 33482039 [TBL] [Abstract][Full Text] [Related]
8. Comprehensive antibody and cytokine profiling in hospitalized COVID-19 patients in relation to clinical outcomes in a large Belgian cohort. Ruytinx P; Vandormael P; Fraussen J; Pieters Z; Thonissen S; Hellings N; Stinissen P; Callebaut I; Penders J; Vanhove K; Kieffer D; Rummens JL; Valkenborgh T; Messiaen P; Stessel B; Mesotten D; Somers V Sci Rep; 2023 Nov; 13(1):19322. PubMed ID: 37935729 [TBL] [Abstract][Full Text] [Related]
9. Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29). Jordan WJ; Eskdale J; Boniotto M; Rodia M; Kellner D; Gallagher G Genes Immun; 2007 Jan; 8(1):13-20. PubMed ID: 17082759 [TBL] [Abstract][Full Text] [Related]
10. Are SARS-CoV-2 Antibodies Detectable in Human Milk After Vaccination Against COVID-19? Scaggs Huang F J Pediatric Infect Dis Soc; 2022 Apr; 11(4):126. PubMed ID: 35394545 [TBL] [Abstract][Full Text] [Related]
11. Anti-SARS-CoV-2 IgG and Neutralizing Antibody Levels in Patients with Past COVID-19 Infection: A Longitudinal Study. Dinç HÖ; Demirci M; Özdemir YE; Sirekbasan S; Aktaş AN; Karaali R; Tuyji Tok Y; Özbey D; Akçin R; Gareayaghi N; Kuşkucu MA; Midilli K; Aygün G; Sarıbaş S; Kocazeybek B Balkan Med J; 2022 May; 39(3):172-177. PubMed ID: 35378574 [TBL] [Abstract][Full Text] [Related]
12. Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Jordan WJ; Eskdale J; Srinivas S; Pekarek V; Kelner D; Rodia M; Gallagher G Genes Immun; 2007 Apr; 8(3):254-61. PubMed ID: 17361203 [TBL] [Abstract][Full Text] [Related]
13. Interferon-lambda1 (interleukin-29) preferentially down-regulates interleukin-13 over other T helper type 2 cytokine responses in vitro. Srinivas S; Dai J; Eskdale J; Gallagher GE; Megjugorac NJ; Gallagher G Immunology; 2008 Dec; 125(4):492-502. PubMed ID: 18547367 [TBL] [Abstract][Full Text] [Related]
15. IFNL1 rs30461 polymorphism as a risk factor for COVID-19 severity: A cross-sectional study. Hammad MO; Alseoudy MM; Borg AM; El-Mesery A; Elgamal M; Abdelghany DA; Elzeiny D Cytokine; 2024 Apr; 176():156500. PubMed ID: 38271827 [TBL] [Abstract][Full Text] [Related]
16. Dysregulated early transcriptional signatures linked to mast cell and interferon responses are implicated in COVID-19 severity. MacCann R; Leon AAG; Gonzalez G; Carr MJ; Feeney ER; Yousif O; Cotter AG; de Barra E; Sadlier C; Doran P; Mallon PW Front Immunol; 2023; 14():1166574. PubMed ID: 37261339 [TBL] [Abstract][Full Text] [Related]